If you've been seeing Moderna (MRNA) pop up in your news feed or investment apps, you're not alone. While known for its COVID-19 vaccine, there's a lot more to this biotech company driving its recent stock movements than meets the eye.
Moderna's stock is making headlines due to recent positive news and investor interest in its pipeline beyond COVID-19.
Investors are closely watching Moderna as it navigates the post-pandemic landscape.